Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,677,211 papers from all fields of science
Search
Sign In
Create Free Account
SH3KBP1 gene
Known as:
CBL-INTERACTING PROTEIN, 85-KD
, SH3KBP1
, SH3-DOMAIN KINASE-BINDING PROTEIN 1
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
SH3KBP1 protein, human
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Transcriptional regulation of NOX genes express ion in human breast adenocarcinoma MCF-7 cells is modulated by adaptor protein Ruk/CIN 85.
A. Bazalii
,
I. Horak
,
G. V. Pasi chn yk
,
S. Komisarenko
,
L. Drobot
Ukrainian Biochemical Journal
2016
Corpus ID: 44551901
NADPH oxidases are key components of redox-dependent signaling networks involved in the control of cancer cell proliferation…
Expand
2014
2014
Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
Gulzar Ahmad
,
Bhopal C. Mohapatra
,
+11 authors
H. Band
International Journal of Biochemistry and Cell…
2014
Corpus ID: 37910859
2014
2014
Multiple molecular forms of adaptor protein Ruk/CIN85 specifically associate with different subcellular compartments in human breast adenocarcinoma MCF-7 cells.
B. Vynnytska-Myronovska
,
Yaroslav Bobak
,
G. Pasichnyk
,
N. Igumentseva
,
A. Samoylenko
,
L. B. Drobot
Ukrainian Biochemical Journal
2014
Corpus ID: 7056492
Ruk/CIN85 is a receptor-proximal 'signalling' adaptor that possesses three SH3 domains, Pro- and Ser-rich regions and C-terminal…
Expand
2013
2013
Adaptor protein complex of FRS2β and CIN85/CD2AP provides a novel mechanism for ErbB2/HER2 protein downregulation
Y. Minegishi
,
Y. Shibagaki
,
+6 authors
N. Gotoh
Cancer Science
2013
Corpus ID: 23394436
Overexpression of the ErbB2/HER2 receptor tyrosine kinase contributes to tumorigenesis. However, mechanisms regulating ErbB2…
Expand
2010
2010
The adaptor protein Ruk/CIN85 activates plasminogen activator inhibitor-1 (PAI-1) expression via hypoxia-inducible factor-1α
A. Samoylenko
,
E. Dimova
,
Nina Kozlova
,
L. Drobot
,
T. Kietzmann
Thrombosis and Haemostasis
2010
Corpus ID: 24258466
Summary Increased levels of plasminogen activator inhibitor-1 (PAI-1) indicate an enhanced risk of ischaemic/hypoxic…
Expand
2010
2010
Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignancies
J. Adélaïde
,
V. Gelsi-Boyer
,
+8 authors
M. Chaffanet
Leukemia
2010
Corpus ID: 35779472
Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignancies
2007
2007
Regulation of the interaction of Disabled‐1 with CIN85 by phosphorylation with Cyclin‐dependent kinase 5
Yutaka Sato
,
M. Taoka
,
+7 authors
S. Hisanaga
Genes to Cells
2007
Corpus ID: 37551476
Disabled‐1 (Dab1) is an adaptor protein mediating Reelin signaling in neuronal migration during brain development. Cyclin…
Expand
2006
2006
Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma.
O. Mayevska
,
H. Shuvayeva
,
+8 authors
L. Drobot
Experimental oncology
2006
Corpus ID: 8372003
AIM Development of monoclonal and polyclonal antibodies against recombinant GST-fused proteins including correspondingly N- and C…
Expand
2005
2005
Overexpression of CIN85 suppresses the growth of herpes simplex virus in HeLa cells.
T. Narita
,
A. Ando
,
Y. Mikami
,
T. Taniyama
Experimental Cell Research
2005
Corpus ID: 2501480
2002
2002
CIN 85 participates in Cbl-b-mediated downregulation of receptor tyrosine kinases
I. Szymkiewicz
,
Katarzyna Kowanetz
,
P. Soubeyran
,
Ana Dinarina
,
S. Lipkowitz
,
I. Dikič
2002
Corpus ID: 42046709
The abbreviations used are: CIN85, Cbl interacting protein of 85 kDa; DMEM, Dulbecco's modified Eagle's medium; DFSP…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE